Reshma Rangwala - 22 Apr 2024 Form 4 Insider Report for Karyopharm Therapeutics Inc. (KPTI)

Signature
/s/Nancy Smith as Attorney-in-Fact for Reshma Rangwala
Issuer symbol
KPTI
Transactions as of
22 Apr 2024
Net transactions value
-$7,943
Form type
4
Filing time
23 Apr 2024, 16:02:01 UTC
Previous filing
04 Mar 2024
Next filing
04 Mar 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KPTI Common Stock Sale $7,943 -6,789 -1.9% $1.17 342,931 22 Apr 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on April 4, 2022, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person.